Linked Life Data

21505295

Source:http://linkedlifedata.com/resource/pubmed/id/21505295

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2011-7-12
pubmed:abstractText
Despite limiting exposure to antiretroviral drugs, structured treatment interruptions can influence multiple aspects of T-cell immunity, particularly those regarding CD4(+) T lymphocytes. We evaluated the impact of CD4-guided treatment interruption (CD4-GTI) and treatment resumption on regulatory T cells (Tregs), T-lymphocyte activation, differentiation and polyfunctional gag-specific response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1473-5571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
31
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1443-53
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption.
pubmed:affiliation
Department of Biomedical Sciences, University of Modena and Reggio Emilia, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't